@ProfAJChalmers FU is short and there is no sham treatment involved to compare. Until now we still have to perform the correct study to prove radiotherapy is here to stay
https://t.co/28ab2wQ4Ck
@NiuSanford abstract: patients receiving radiotherapy (RT) during “dark” season (fall/winter) may have better outcomes than those treated during ”light” season (spring/summer), possibly secondary to seasonal variations in cell cycle progression
@DrewMoghanaki@Mat_Guc@PBlanchardMD i think it will be still hard to contour cardiac substructures. We recently published a suggested update on the Feng paper including 3D-contouring based on contrast enhanced CTs.
https://t.co/vgdvwnpaNh
@toddscarbrough@SprakerMDPhD@LindsayPhys@SbrtSean i do think this could be right. Varian put all there money on ETHOS and hypersight. Perhaps Elekta can buy it to use the rights as mentioned on their own Unity. Time will tell what will happen, bad day for #radonc anyway.